Skip to main content

MDS 2017

  • Day 1
  • Day 2
  • Day 3
  • Day 4
  • Agenda

Mutational Signature and Clonal Architecture of Low Risk Myelodysplastic Syndromes?with del(5q)

May 7, 2017August 13, 2017 liorco70

http://d22fjzb79sfamb.cloudfront.net/MDS2017/sat/1030%20-%201230/Sat%201110.mp4

V. Adema (USA)

Post navigation

An Analysis of the Transcriptional Response of Myelodysplastic Syndrome Stem Cells to Therapy at Single Cell Resolution
Labile Plasma Iron predicts for survival in patients undergoing allogeneic-stem cell transplantation – results from the prospective multicenter German-Austrian ALLIVE trial.

Day 4

Best Abstracts: TITO BASTIANELLO AND MDS FOUNDATION YOUNG INVESTIGATORS AWARD

  • 10:30 Y. Hayashi (USA)
  • 10:50 S. Chung (USA)
  • 11:10 V. Adema (USA)
  • 11:30 M. Wermke (Germany)

Plenary Session: CLOSING REMARKS AND FAREWELL

  • 12:00 Lars Kjeldsen , Kirsten Gronbaek (Denmark)
sparkling Theme by Colorlib Powered by WordPress